Treatment

Yoga Equally Effective as PT for Chronic Low Back Pain

Yoga Equally Effective as PT for Chronic Low Back Pain

By

In a randomized trial that compared the efficacy of yoga, physical therapy, and education for patients with chronic low back pain, yoga was deemed noninferior to PT.

Adverse Effects Linked to Chronic Lyme Disease Treatments

Adverse Effects Linked to Chronic Lyme Disease Treatments

During the treatment for chronic Lyme disease, serious bacterial infections have been documented.

Simplified Combination Tx for Early Rheumatoid Arthritis Is Safe, Effective

Simplified Combination Tx for Early Rheumatoid Arthritis Is Safe, Effective

By

COBRA is a combination therapy regimen for RA that has been shown to be safe and effective in the early stages of RA for improving short- and long-term outcomes.

Shock Wave Therapy Treatment for Arthralgia in RA Patients

Shock Wave Therapy Treatment for Arthralgia in RA Patients

Significant reductions in VAS scores, morning stiffness duration in case series of 15 patients

Use of Opioid Prior to TKA Associated With Worse Post-Op Pain

Use of Opioid Prior to TKA Associated With Worse Post-Op Pain

Researchers suggest that limiting opioid prescriptions might optimize benefits of TKA.

Does Sedative Use Increase Repeat Fall Risk?

Does Sedative Use Increase Repeat Fall Risk?

Poor quality of sleep and excessive daytime sleepiness are a risk for recurrent falls.

Lesinurad, Febuxostat Combination Treatment Improves Tophaceous Gout Symptoms

Lesinurad, Febuxostat Combination Treatment Improves Tophaceous Gout Symptoms

By

Patients with tophaceous gout undergoing combination therapy with lesinurad and febuxostat showed a greater degree of symptom resolution than with febuxostat monotherapy.

Analysis of Factors Improving Rx Adherence in Patients with Gout

Analysis of Factors Improving Rx Adherence in Patients with Gout

Belief about medicines, presence of comorbidity, and being married positively influence adherence to medication.

Common Rheumatoid Arthritis Drugs May Increase Risk for Herpes Zoster

Common Rheumatoid Arthritis Drugs May Increase Risk for Herpes Zoster

By

Common rheumatoid arthritis drugs methotrexate and biologics, but not prednisolone, may increase the risk for herpes zoster.

Tofacitinib Found to Improve Nail Psoriasis

Tofacitinib Found to Improve Nail Psoriasis

There was improvement in nail psoriasis severity at 16 weeks compared with placebo that was maintained through 52 weeks.

Is Low-Dose Methotrexate Sufficient in Patients With Rheumatoid Arthritis?

Is Low-Dose Methotrexate Sufficient in Patients With Rheumatoid Arthritis?

By

The efficacy of lower doses of MTX in patients with rheumatoid arthritis in combination with ADA was studied.

Hydrotherapy Plus Conventional Drugs Beneficial in Rheumatoid Arthritis

Hydrotherapy Plus Conventional Drugs Beneficial in Rheumatoid Arthritis

There was a significant change in oxidative stress biomarkers and a decrease in activities of antioxidant enzymes.

No Negative Effect on Disease Activity Seen in Switching Patients to Biosimilar Infliximab From Originator Drug

No Negative Effect on Disease Activity Seen in Switching Patients to Biosimilar Infliximab From Originator Drug

By

Researchers found similar disease duration the 3 months before and after the switch to CT-P13 in patients.

FDA Approves First Drug to Specifically Treat Giant Cell Arteritis

FDA Approves First Drug to Specifically Treat Giant Cell Arteritis

By

Actemra (tocilizumab) has been FDA-approved for its use in giant cell arteritis treatment.

Some Knee Osteoarthritis Pain Relief From Curcuminoids

Some Knee Osteoarthritis Pain Relief From Curcuminoids

There was reduced knee pain and improved quality of life vs placebo, but less pain relief than ibuprofen.

Prolonged Hypocalcemia Induced by Denosumab: A Case Study

Prolonged Hypocalcemia Induced by Denosumab: A Case Study

By

Case study of an 83-year-old male patient who developed severe hypocalcemia induced by denosumab.

Antipsychotic Nonadherence Greater Than for Somatic Illness Due to Social Stigma

Antipsychotic Nonadherence Greater Than for Somatic Illness Due to Social Stigma

By

Schizophrenia was perceived as more distressful and with higher perceived social stigma than the other disorders analyzed.

Osteoporosis Treatment Receives Updated Guidelines From ACP

Osteoporosis Treatment Receives Updated Guidelines From ACP

By

The American College of Physicians has updated its 2008 guidelines on treating low bone density and osteoporosis to prevent fractures.

Low Disease Activity After Tofacitinib Discontinuation in Rheumatoid Arthritis

Low Disease Activity After Tofacitinib Discontinuation in Rheumatoid Arthritis

By

Researchers found that one-third of patients remain in remission after discontinuing tofacitinib and that low baseline RF titers predict low disease activity after tofacitinib discontinuation.

International Panel Releases Guidelines for Biologics Use in Lupus

International Panel Releases Guidelines for Biologics Use in Lupus

By

The guidelines were established by a mutidisciplinary group of experts with a goal of optimizing lupus outcomes for all patients.

FDA: Biologics Application for Subcutaneous Rituximab Accepted

FDA: Biologics Application for Subcutaneous Rituximab Accepted

By

The US Food and Drug Administration (FDA) has accepted Genentech's Biologics License Application for a subcutaneous formulation of rituximab.

Acceptance, Rejection of RA Treatment Linked to Patient Personality

Acceptance, Rejection of RA Treatment Linked to Patient Personality

Researchers examined the association between personality-related variables and aggressive treatment, and the affect on patient treatment options.

Management of Inflammatory Arthritis in Patients With Comorbid HIV Infection

Management of Inflammatory Arthritis in Patients With Comorbid HIV Infection

By

Challenges of managing inflammatory arthritis in patients infected with HIV include difficulties in assessing disease activity and limited safety information for the use of immunosuppresive drugs in this patient population.

Safety and Efficacy of Certolizumab Pegol for Rheumatoid Arthritis

Safety and Efficacy of Certolizumab Pegol for Rheumatoid Arthritis

By

A 16-week, open-label extension of the REALISTIC phase 3b trial shows rapid and sustained clinical improvements with certolizumab pegol in patients with RA.

Sign Up for Free e-newsletters